• News
  • HanaVax Inc. is elected as a ‘Final 10’ from Japan, will participate in ‘London Demo Day (Nov 21 & 22)’; a global pitch event organized by MRI and Oxentia, Ltd.
  • News
  • Prof. Yuichi Kurono, department chairman of Kagoshima University Graduate School of Medical and Dental Sciences joined the HanaVax‘s Scientific Advisory Board.
  • News
  • HanaVax Inc. has raised funds from Fast Track Initiative, Inc., SMBC Venture Capital, Nishihara Shokai Co., Ltd. and Kondo Cotton Spinning Co., Ltd.
  • News
  • President & CEO of our company attended 2018 BIO International Convention at Boston. Partnering meeting with Pharma showing interest in our platform technologies and lead product.
  • News
  • Based on our research team latest finding; a novel patent for vaccine development will be drafted.
  • News
  • Recent Publications

    Nanogel-based nasal vaccines for infectious and lifestyle-related diseases.
    Azegami T, Yuki Y, Nakahashi R, Itoh H, Kiyono H.
    Mol Immunol. 2017 Oct 30. pii: S0161-5890(17)30551-5.
    doi:10.1016/j.molimm.2017.10.022. [Epub ahead of print]

    Development of a nanogel-based nasal vaccine as a novel antigen delivery system.
    Nakahashi-Ouchida R, Yuki Y, Kiyono H.
    Expert Rev Vaccines. 2017 Oct 27:1-10.
    doi: 10.1080/14760584.2017.1395702. [Epub ahead of print]

  • Event
  • You are invited to meet with our speaker at the following meetings

    June 23, Fri
    RIKEN IMS-JSI International Symposium on Immunology, “Mucosal Trio-regulatory Machinery of Epithelial Cells-Innate Lymphoid Cells-Commensal Bacteria for Gut Homeostasis and Inflammation,” Dr. Kiyono as Invited Speaker, Tokyo, Japan

    Oct, 2017
    ISV Congress 2017, Dr. Kiyono as Invited Speaker, Paris, France

    Oct 19, 2017
    La Jolla Immunology Conference, Session on Immunity at Mucosal Barriers, Dr. Kiyono as Invited Speaker, CA, USA